Systematic review and meta-analysis to compare success rates of retrograde intrarenal surgery versus percutaneous nephrolithotomy for renal stones >2 cm: An update. by 강승구 et al.
Systematic Review and Meta-Analysis Medicine®
OPENSystematic review and meta-analysis to compare
success rates of retrograde intrarenal surgery
versus percutaneous nephrolithotomy for renal
stones >2cm
An update
Sung Ku Kang, MDa, Kang Su Cho, MD, PhDb, Dong Hyuk Kang, MDc, Hae Do Jung, MDd,
Jong Kyou Kwon, MDe, Joo Yong Lee, MD, PhDa,
∗
Abstract
Background: We performed a systematic review and meta-analysis comparing stone-free rates between retrograde intrarenal
surgery (RIRS) and percutaneous nephrolithotomy (PCNL), using updated, more reliable evidence.
Materials and methods: Randomized controlled trials comparing RIRS and PCNL for >2cm stones were identified from
electronic databases. Stone-free rates for the procedures were compared by qualitative and quantitative syntheses (meta-analyses).
Outcome variables are shown as risk ratios (RRs) with 95% confidence intervals (CIs).
Results: Eleven articles were included in this study. Most recently published studies exhibited relatively low quality during quality
assessment. For themeta-analysis comparing success (stone-free) rates between PCNL and RIRS, the forest plot using the random-
effects model showed an RR of 1.11 (95%CI 1.02–1.21, P< .014) favoring PCNL. After determining the among-study heterogeneity,
subgroup analysis was performed of 9 studies with less heterogeneity: the stone-free rate of PCNL was superior to that of RIRS using
a fixed-effect model (RR 1.07, 95% CI 1.01–1.14, P< .019) for these studies.
Conclusions: RIRS can be a safe and effective procedure for selected patients with large renal stones. However, in this meta-
analysis, the postoperative stone-free rate of PCNL was higher than that of RIRS in patients with >2cm renal stones.
Abbreviations: CI = confidence interval, EAU = European Association of Urology, MD =mean difference, PCNL = percutaneous
nephrolithotomy, RIRS = retrograde intrarenal surgery, RR = risk ratio, SWL = shock wave lithotripsy.
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most popular surgical treatments for renal stones. With the
advent of newer-generation flexible ureterorenoscopes, Holmi-
um:YAG laser lithotripsy, and natural orifice translumenal
endoscopic surgery, RIRS has been gaining popularity among
urologists and is widely accepted as an alternative to SWL for
the management of renal stones. However, the drawbacks of
retrograde access include limited visualization, restrictions on
the size of fragments that can be removed, and the requirement
for stone lithotrites and baskets.[2] In the European Association
of Urology (EAU) Guidelines on Urolithiasis, SWL and RIRS
are suggested equally as treatment methods for renal stones less
than 2cm diameter,[3] but for stones larger than 2cm, PCNL is
recommended as the first-line treatment.[4] In the EAU guide-
lines, RIRS and SWL are not recommended as first-line
treatments for larger stones in uncomplicated cases, as stone-
free rates are less than those with PCNL, and staged procedures
have become necessary.[5,6] However, several researchers have
reported that RIRS is feasible for stones larger than 2cm and
produces stone-free rates that are similar to those achieved with
PCNL.[7]
Based on these results, in 2014, Zheng et al[8] published a
meta-analysis comparing the outcomes of RIRS and PCNL for
renal stones larger than 2cm. The current study includes
additional articles published since 2014, and also re-analysis of
stone-free rates. Re-analysis in the current study can be
Kang et al. Medicine (2017) 96:49 Medicinemodified due to bias that may already exist in published studies,
to show more clear results of treatment outcomes for RIRS and
PCNL.2. Materials and methods
2.1. Inclusion criteria
Published studies that met the following criteria were
included: (1) a study design that included comparisons of
success rates or stone-free rates between PCNL and RIRS in
patients with renal calculi larger than 2cm; (2) a study that
provided accurate information about perioperative variables,
including the number of patients and number of success or
stone-free cases; and (3) the full text of the study or abstract
presented at a scientific congress could be accessed. The study
was exempt from requiring approval of ethics committee or
institutional review board because of systematic review and
meta-analysis.2.2. Search strategy
A literature search was performed for all studies published before
January 31, 2016, in the PubMed and EMBASE online databases.
A cross-reference search of the eligible articles was performed to
identify additional studies not found by the computerized search.
A combination of the following MeSH terms and keywords was
used: renal calculi, percutaneous nephrolithotomy, flexible
ureteroscopy, and retrograde intrarenal surgery. Chinese data
from 4 articles were obtained from a previous meta-analysis by
Zheng et al.[8]2.3. Study selection and data extraction
One researcher screened the titles and abstracts identified by the
search strategy (SKK). Two other researchers independently
assessed the full text of the papers to determine whether they met
the inclusion criteria (DHK and JKK). The most relevant data
were extracted from each study with respect to the author, year of
publication, patient demographics, treatments, fertility rates, and
inclusion of a reference standard. For the study selection and data
extraction processes, disagreements were resolved by discussion
until a consensus was reached or by arbitration involving another
researcher (JYL).2.4. Study quality assessment and publication bias
Once the final group of articles was agreed upon, 2 researchers
independently examined the quality of each article using the
Downs and Black checklist. The Downs and Black checklist was
developed for the purpose of quality assessment of both
randomized and nonrandomized studies of health interven-
tions.[9] The checklist consists of 5 subscales: reporting, internal
validity bias, internal validity confounding, external validity, and
power. Because 6 items in the original list were related to
intervention, randomization, and power calculation, and not all
of the studies examined were randomized studies, the scores for
these 6 items were counted as 0, as suggested by a previous
study.[10] Therefore, the maximum quality score was 31 points. A
higher score was considered to be an indicator of a good quality
study.More detailed descriptions of each item have been reported
elsewhere.[11] However, 4 studies by Zheng et al[8] were not
included in quality assessment.2
2.5. Heterogeneity tests
Heterogeneity among studies was explored using the Q statistic
and the Higgins I2 statistic.[12] Higgins I2 measures the
percentage of total variation across studies due to heterogeneity
rather than chance. An I2 greater than 50% is considered to
represent substantial heterogeneity. Higgins I2 is calculated as
follows:
I2 ¼ Q df
Q
 100%
where “Q” is Cochran heterogeneity statistic and “df” is the
degrees of freedom.
For the Q statistic, heterogeneity was deemed to be significant
if the P value was less than .10.[13] When there was evidence of
heterogeneity, the data were analyzed using a random-effects
model to obtain a summary estimate for the test sensitivity with
95% confidence intervals (CIs) and mean differences (MDs).
Studies in which positive results were confirmed were conducted
using a pooled specificity with 95% CIs. In addition, Galbraith
radial plots were performed to evaluate heterogeneity.[14,15]2.6. Statistical analysis
When a significant Q-test indicated heterogeneity across studies
(P< .10) or the I2 was more than 50%, the random-effects model
was used for the meta-analysis; otherwise, the fixed-effect model
was employed.[16] Meta-analyses of comparable data were
performed using R (version 3.3.1, R Foundation for Statistical
Computing, Vienna, Austria; http://www.r-project.org) and its
meta and metafor packages.3. Results
3.1. Eligible studies
The database search found 32 articles that could be potentially
included in the meta-analysis. Based on the inclusion and
exclusion criteria, 21 articles were excluded after a simple reading
of the titles and abstracts of the articles, and 2 articles were
excluded because the patient population did not meet the
inclusion criteria. In total, 11 articles were included in the
analysis of the success or stone-free rates after PCNL or RIRS
(Fig. 1).[17–27] In Table 1, we summarize the enrolled studies
except for the 4 Chinese articles by Zheng et al.[24–27]
3.2. Quality assessment
The results of quality assessment based on the Downs and Black
checklist are shown in Table 1. The median of the total quality
scores was 13. Overall, the quality scores within subscales were
relatively low. External validity, in particular, was not
satisfactory for both significant and insignificant groups in most
studies.3.3. Publication bias
The Begg and Mazumdar rank correlation tests for each analysis
showed no evidence of publication bias in the present meta-
analysis (P= .283). Egger regression intercept tests also revealed
no evidence of publication bias (P= .093). The funnel plot for all
studies included in the meta-analysis is shown in Fig. 2A; they
show that 3 studies were located outside the funnel shape,
Table 1
Studies included in this meta-analysis
∗
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NA, not available; No., number; PCNL, percutaneous nephrolithotomy; RCT, randomized controlled trial; RIRS, retrograde intrarenal surgery.
∗
Excluding 4 studies from the Zeng et al meta-analysis.
† In RIRS, stone-free rates showed 95.7% in middle calyx, 84.6% in renal pelvis, 72.4% in upper calyx, and 62.1% in lower calyx. However, in PCNL, second procedures were performed in only 2 cases.
‡ In PCNL, 3 lower poles and 4 partial staghorn stones were enrolled. In RIRS, 1 lower pole and 3 partial staghorn stones were enrolled.
x In PCNL, 6 upper, 2 middle, 14 lower calyceal stones, and 12 renal pelvis stones were enrolled. In RIRS, 6 upper, 2 middle, 15 lower calyceal stones, and 11 renal pelvis stones were enrolled.
¶ In PCNL, 7 middle, 12 lower calyceal stones, 39 renal pelvis stones, and 8 complex stones were enrolled. In RIRS, 7 upper, 10 middle, 17 lower calyceal stones, 15 renal pelvis stones, and 8 complex stones
were enrolled.
Figure 1. Flow diagram of study selection. Eleven studies were ultimately included in the qualitative and quantitative synthesis (including meta-analysis).
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Figure 2. Funnel plots of all studies (A), and also for the studies selected for quality assessment (B) and the final sensitivity analysis (C). Little evidence of publication
bias was demonstrated by visual or statistical examination of these funnel plots.
Kang et al. Medicine (2017) 96:49 Medicineindicating that there was little publication bias in this meta-
analysis.
3.4. Heterogeneity assessment and results from forest
plots
Forest plots for the success or stone-free rates are shown in Fig. 3.
Heterogeneity testing demonstrated that there was some
heterogeneity (P< .001, I2=70.4%); thus, random-effects mod-
els were used to further assess these variables. In the L’Abbe plot,
there was no heterogeneity using a random-effects model
(Fig. 4A); however, in Galbraith radial plot, 2 studies
demonstrated heterogeneity after selection of effect models for
each variable (Fig. 5A). Thus, subgroup analysis was performed
excluding these 2 studies (the results of which are described in a
later section).
In a meta-analysis comparing the success or stone-free rates of
PCNL versus RIRS, the forest plot using the random-effects
model showed a risk ratio (RR) of 1.113 (95% CI 1.021–1.213,
P= .015), favoring PCNL (Fig. 3).3.5. Subgroup analysis of the studies undergoing quality
assessment
Seven studies were enrolled in the subgroup analysis of studies
that underwent quality assessment. In this forest plot, the stone-
free rate of PCNLwas favorable compared with that of RIRS (RR
1.183, 95% CI 1.048–1.336, P= .007) using the random-effectsFigure 3. Meta-analysis of all 11 included studies. The stone-free rate of
percutaneous nephrolithotomy (PCNL) was superior to that of retrograde
intrarenal surgery (RIRS).
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model (Fig. 6). In the L’Abbe plot, there was no heterogeneity
using the random-effects model (Fig. 4B); however, in the radial
plot, a study was located outside the effective model periods
(Fig. 5B). Also, there were 2 studies outside the funnel shape in the
funnel plot (Fig. 2B).
3.6. Subgroup analysis after excluding the 2 studies
producing heterogeneity
In Galbraith radial plot, 2 studies, including those of Pan et al and
Karakoc et al,[17,22] produced heterogeneity; these 2 studies were
excluded and subgroup analysis was performed. All of the
remaining 9 studies were located within the funnel plot (Fig. 2C),
and in the L’Abbe plot and radial plot, all studies demonstrated
no heterogeneity (Figs. 4C and 5C). In the forest plot, the stone-
free rate of PCNL was superior to that of RIRS using the fixed-
effect model (RR 1.072, 95% CI 1.011–1.135, P= .019) (Fig. 7).
3.7. Meta-analysis for operation time and hospital stay
Six studies were enrolled in meta-analysis for operation time.
Forest plot showed that operation time of PCNLwas shorter than
that of RIRS (MD 15.65, 95% CI 25.63 to 5.67, P= .002),
using random-effects model (Fig. 8A). However, in forest plot for
hospital stay, RIRS was favorable compared with that of RIRS
(MD 2.21, 95% CI 0.49–3.93, P= .012) (Fig. 8B).
4. Discussion
Aboumarzouk et al[7] compiled the results of previously
published studies evaluating the use of RIRS for renal stones
larger than 2cm. They included 9 studies and reported an average
total stone-free rate of 93.7% and a complication rate of 10.1%;
this represents generally successful outcomes after this surgery. In
2014, Zheng et al[8] reported the results of their meta-analysis
comparing RIRS and PCNL treatment for stones larger than 2
cm. They enrolled 8 studies and reported stone-free rates, mean
operative times, mean hospital lengths of stay, and complication
rates. Of note, RIRS and PCNL showed no significant difference
in stone-free rates (RR 0.95, 95% CI 0.88–1.02). This result
contradicted recommendations in the EAU Guidelines on
Urolithiasis and brought confusion to urologists and general
physicians.[4] The EAU guidelines suggested that RIRS should not
Figure 4. L’Abbe plots including all studies (A), and also the studies selected for quality assessment (B) and the final sensitivity analysis (C). PCNL, percutaneous
nephrolithotomy; RIRS, retrograde intrarenal surgery.
Kang et al. Medicine (2017) 96:49 www.md-journal.combe used as the first-line treatment for renal stones larger than 2
cm, and that PCNL is the treatment of choice for these large
stones.[28]
Our results showed that PCNL was associated with a better
stone-free rate than RIRS (RR 1.113, 95% CI 1.021–1.213).
Among the added studies conducted in 2015 and 2016, 2 reports
showed insignificant difference between RIRS and PCNL,
whereas another study suggested that PCNL produces a better
stone-free rate.[21–23] Karakoyunlu et al[21] performed RIRS and
PCNL on 30 patients with renal stones bigger than 2cm after
randomizing the subjects to 1 of these treatments. There was no
significant difference in stone-free rates between procedures
(P= .067), and the authors concluded that RIRS was not superior
to PCNL because of the need for multiple sessions and its long
treatment time. In their study, only 6 cases (20%) were first
session stone-free, whereas 16 cases (54%) were second session
stone-free in RIRS group; however, in PCNL group, 26 cases
(86%) showed stone-free status.[21] Karakoc et al performed a
retrospective analysis of 143 patients, 86 of underwent PCNL,
and 57 of underwent RIRS. Although the PCNL group had a
higher mean stone size than the RIRS group (2.93±0.71 vs 2.50
±0.66), the PCNL group demonstrated a higher stone-free rate.
In their study, complications were seen more frequently in PCNL
group. Blood transfusions were required in 2 patients whoFigure 5. Galbraith radial plots of total studies (A), and also the studies s
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underwent PCNL; however, none of the patients in RIRS group
required blood transfusion. Postoperative fever was seen in 9
patients in PCNL group; however, no patients in RIRS group had
this complication. The authors considered comorbidities in
patients with stones larger than 2cm and concluded that RIRS is
recommended for stones larger than 2cm.[22] Palmero et al
performed a retrospective analysis of 142 patients with renal
stones (106 underwent RIRS and 36 underwent PCNL). Their
PCNL group also exhibited a higher success rate than the RIRS
group (80.6% vs 73.6%, respectively), although the difference in
rates between groups was not statistically significant (P= .40).
The authors concluded that RIRS could be an alternative to
PCNL for 2 to 3.5-cm renal stones. All 3 additional studies
reported stone-free rates with RIRS that were relatively lower
than those seen with PCNL.[21–23]
In the meta-analysis by Zheng et al, with regard to
postoperative complications, which are commonly considered
to be a disadvantage of PCNL, RIRS and PCNL showed no
differences in most complications. The only difference was for
postoperative bleeding, which was more likely after PNCL (RR
0.20, 95% CI 0.06–0.68). However, in the literature, compli-
cations of grade 2 and over have been reported at rates of 9.48%
for PCNL. This discrepancy may be explained by the limited
number of cases included in the meta-analysis by Zheng et al,elected for quality assessment (B) and the final sensitivity analysis (C).
Figure 7. Meta-analysis of studies selected for the final sensitivity analysis
(excluding 2 studies primarily responsible for the among-study heterogeneity).
The stone-free rate for percutaneous nephrolithotomy (PCNL) was superior to
retrograde intrarenal surgery (RIRS) using the fixed-effect model.
Figure 6. Meta-analysis of studies selected for quality assessment. The stone-
free rate of percutaneous nephrolithotomy (PCNL) was superior to that of
retrograde intrarenal surgery (RIRS) in selected studies excluding Chinese 4
studies, which were not obtained as full-text in the Medline and EMBASE
databases.
Kang et al. Medicine (2017) 96:49 Medicinewhich limited its ability to show the true spectrum of
complications. One of the limitations of the existing meta-
analysis is that an analysis of pain, which is the most complex
postoperative complication, was not performed. Painmay ormay
not be manifest, depending on the method of PCNL,[29] and the
existence of indwelling double-J ureteric stents is another factor
that affects postoperative discomfort.[30]
The current meta-analysis compared postoperative stone-free
rates. In addition, operation time and hospitals stay were
analyzed by random-effect models (Fig. 8). The results on
operation time and hospital stay in the current study showed
same results from previous meta-analysis. However, they showed
different results for postoperative stone-free rates. In the study by
Zheng et al, quantitative analysis showed an I2 of 55% and severe
heterogeneity with P= .03, and our meta-analysis also showed an
I2 of 70.4% and severe heterogeneity with P< .001. Neverthe-
less, in the current study, the random-effects model by
heterogeneity was selected before using L’Abbe plot and radial
plot to test the sensitivity of the selection model. Subgroup
analysis was performed after excluding the 2 studies primarily
responsible for the heterogeneity and again showed slightly betterFigure 8. Meta-analysis for operation time and hospital stay between percutaneo
operation time, that of PCNL was shorter than RIRS (MD15.65, 95%CI25.63 t
to that of RIRS (MD 2.21, 95% CI 0.49–3.93, P= .012). CI=confidence interval,
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stone-free rates with PCNL (RR 1.07, 95% CI 1.01–1.14). All of
these results showed high consistency that PCNL was superior to
RIRS in stone-free rate. In particular, the final result was more
reliable in that it was acquired after eliminating heterogeneity
through sensitivity selection.
One of the limitations in our current meta-analysis was that it
demonstrated no comparison of stone shape and number of
involved calyces between PCNL and RIRS groups. If a recent
nephrolithometry score was reflected,[31–33] a complete assess-
ment of stone-free rate of PCNL and RIRS would have been
possible. However, the current study only analyzed the results of
studies that were included in our meta-analysis, because all
enrolled studies did not present nephrolithometry scores or
detailed stone characteristics. Another limitation was the
inclusion of retrospective studies leading to a relatively low level
of evidence. Only 2 randomized studies were included that
compared RIRS and PCNL for renal stones bigger than 2cm.
Because only 2 randomized trials were reported, PCNL can be the
treatment of choice according to recommendation of EAU
guidelines. However, the development of the videoscope and
digital ureterorenoscope, and also endourologic procedures, mayus nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS). (A) In the
o5.67, P= .002). (B) However, in hospital stay, RIRS was favorable compared
MD=mean difference.
[34,35] [15] Kang DH, Cho KS, Ham WS, et al. A systematic review and meta-
Kang et al. Medicine (2017) 96:49 www.md-journal.comcontribute to a higher stone-free rate with RIRS. In
addition, RIRS has the advantage of being possible in selected
patients who are not candidates for PCNL. In patients with a
bleeding disorder, or those who require urinary diversion and a
percutaneous antegrade approach for ureter stones, RIRS is
superior to PCNL. Endoscopic combined intrarenal surgery using
flexible ureteroscopy andminiature PCNL (endoscopic combined
intrarenal surgery), or extracorporeal lithotripsy (lithotripsy
endoscopically controlled by ureterorenoscopy) increase the
likelihood of positive surgical outcomes, especially in complex
renal stone cases. Advanced RIRS may now offer higher rates of
primary success with minimal side effects, which could outweigh
its slightly higher degree of invasiveness compared with SWL.5. Conclusions
RIRS can be a safe and effective procedure for selected patients
with large renal stones. However, in this meta-analysis, the
postoperative stone-free rate with PCNL was higher than that
with RIRS in patients with renal stones larger than 2cm. Future
randomized trials are required to confirm these results.References
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